Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 150 of 420 entries
View as:

Head Stabilization in Whole Brain RT

Phase: N/A Priority: Normal
NCT ID: NCT06776406 Org: User:
Start: 08/31/25 End: 08/31/27 Due: 08/31/28

Anti-TGF Monoclonal Antibody (GC1008) in Relapsed Malignant Pleural Mesothelioma

Phase: N/A Priority: Normal
NCT ID: NCT01112293 Org: User:
Start: 04/30/10 End: 12/31/14 Due: 12/31/15

Improving Clinical Trial Awareness in NSCLC: Pilot Testing A Novel Healthcare IT Platform for Incorporating Education at the Point of Care

Phase: N/A Priority: Normal
NCT ID: NCT02558998 Org: User:
Start: 03/31/15 End: 03/31/19 Due: 03/31/20

Young Adults and Low Nicotine Cigarettes

Phase: N/A Priority: Normal
NCT ID: NCT03699865 Org: User:
Start: 10/31/24 End: 10/31/24 Due: 10/31/25

Assessing Perceptions of ML Explanations by Medical Oncologists

Phase: N/A Priority: Normal
NCT ID: NCT06699615 Org: User:
Start: 12/02/24 End: 04/15/25 Due: 04/15/26

PROStep: A Feasibility Trial Using PROs and Step Data to Monitor Patients With Lung and GI Cancers

Phase: N/A Priority: Normal
NCT ID: NCT04616768 Org: User:
Start: 11/19/20 End: 12/17/21 Due: 12/17/22

Prospective Follow-up of Outcomes in Patients Receiving Photodynamic Therapy for Neoplastic Diseases

Phase: N/A Priority: Normal
NCT ID: NCT02159742 Org: User:
Start: 07/31/11 End: 12/31/27 Due: 12/31/28

Cognitive Behavioral Therapy With or Without Armodafinil in Treating Cancer Survivors With Insomnia and Fatigue After Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT01019187 Org: User:
Start: 06/30/09 End: 08/31/15 Due: 08/31/16

A Phase I-II Open Label Non-Randomized Study Using TL32711 for Patients With Acute Myelogenous Leukemia, Myelodysplastic Syndrome and Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01486784 Org: User:
Start: 11/30/11 End: 04/30/15 Due: 04/30/16

A Study of Effects of Fesoterodine in Men at High Risk for Overactive Bladder/Detrusor Overactivity Post Robotic-Assisted Lap. Prostatectomy

Phase: N/A Priority: Normal
NCT ID: NCT01661166 Org: User:
Start: 01/31/12 End: 04/15/13 Due: 04/15/14

Ablative Fractional Laser for Sclerotic GVHD-Associated Joint Contractures

Phase: N/A Priority: Normal
NCT ID: NCT02881047 Org: User:
Start: 11/11/13 End: 08/19/16 Due: 08/19/17

Bio-marker Analysis Using Circulating Tumor Cells in Patients With Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT02828345 Org: User:
Start: 11/30/13 End: 12/31/13 Due: 12/31/14

Early FDG PET in Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT02716077 Org: User:
Start: 03/31/16 End: 03/31/21 Due: 03/31/22

QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06551116 Org: User:
Start: 10/10/24 End: 09/01/29 Due: 09/01/30

Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions

Phase: N/A Priority: Normal
NCT ID: NCT00066404 Org: User:
Start: 04/30/03 End: 01/31/06 Due: 01/31/07

Hydroxychloroquine and Temozolomide in Treating Patients With Metastatic or Unresectable Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00714181 Org: User:
Start: 06/30/08 End: 06/30/13 Due: 06/30/14

Single Nucleotide Polymorphism (SNP) Panels and Risk Assessment in Women Undergoing Mammography

Phase: N/A Priority: Normal
NCT ID: NCT01124019 Org: User:
Start: 02/28/10 End: 10/31/12 Due: 10/31/13

Patient-Centered Acupuncture for Pain (PCAP)

Phase: N/A Priority: Normal
NCT ID: NCT02152020 Org: User:
Start: 05/31/14 End: 01/31/15 Due: 01/31/16

A Phase-I, Dose Escalation Study of Recombinant Human Interleukin-18 (Sb-485232) Combined With Adoptive Transfer of Vaccine-Primed CD3/CD28-Costimulated Autologous T-Cells Following Lymphodepletion for Adult Patients With Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02277392 Org: User:
Start: 09/30/14 End: - Due: -

Pazopanib/DCE-MRIs in Renal Cell Carcinoma (RCC)

Phase: N/A Priority: Normal
NCT ID: NCT01221506 Org: User:
Start: 10/31/10 End: 04/30/19 Due: 04/30/20

Yoga for Solid Tumor

Phase: N/A Priority: Normal
NCT ID: NCT03728205 Org: User:
Start: 12/15/18 End: 01/14/21 Due: 01/14/22

F18 EF5 PET/CT Imaging in Patients With Brain Metastases From Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01985971 Org: User:
Start: 03/31/11 End: 08/19/16 Due: 08/19/17

Infusional C-myb ASODN in Advanced Hematologic Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT00780052 Org: User:
Start: 09/30/02 End: 08/31/11 Due: 08/31/12

Autophagy Induction After Bortezomib for Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT01594242 Org: User:
Start: 07/10/12 End: 03/02/15 Due: 03/02/16

Nudge Strategies for DPYD Testing in Patients With Gastrointestinal Cancers Treated With Fluoropyrimidines

Phase: N/A Priority: Normal
NCT ID: NCT06559462 Org: User:
Start: 09/19/24 End: 08/31/25 Due: 08/31/26